Novavax (NVAX) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $9.21 +0.88%
EPS Growth %: -164.5%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -164.5%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $7.7 million versus the consensus estimate of $9.4 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Tutor Perini launches $400M senior notes offering due 2033
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
